vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and HOVNANIAN ENTERPRISES INC (HOV). Click either name above to swap in a different company.

HOVNANIAN ENTERPRISES INC is the larger business by last-quarter revenue ($817.9M vs $749.2M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs -0.1%, a 3.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs -16.5%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 17.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Hovnanian Enterprises, Inc. is an American real estate company which is involved in every aspect of marketing homes, including design, construction and sales. The company works with individual detached housing as well as higher-occupancy dwellings, including townhouses, condominiums and retirement homes.

CLOV vs HOV — Head-to-Head

Bigger by revenue
HOV
HOV
1.1× larger
HOV
$817.9M
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+78.6% gap
CLOV
62.0%
-16.5%
HOV
Higher net margin
CLOV
CLOV
3.7% more per $
CLOV
3.6%
-0.1%
HOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
17.3%
HOV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
HOV
HOV
Revenue
$749.2M
$817.9M
Net Profit
$27.3M
$-667.0K
Gross Margin
Operating Margin
3.6%
-0.5%
Net Margin
3.6%
-0.1%
Revenue YoY
62.0%
-16.5%
Net Profit YoY
-100.7%
EPS (diluted)
$0.05
$-0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
HOV
HOV
Q1 26
$749.2M
Q4 25
$487.7M
$817.9M
Q3 25
$496.6M
$800.6M
Q2 25
$477.6M
$686.5M
Q1 25
$462.3M
$673.6M
Q4 24
$337.0M
$979.6M
Q3 24
$331.0M
$722.7M
Q2 24
$356.3M
$708.4M
Net Profit
CLOV
CLOV
HOV
HOV
Q1 26
$27.3M
Q4 25
$-49.3M
$-667.0K
Q3 25
$-24.4M
$16.6M
Q2 25
$-10.6M
$19.7M
Q1 25
$-1.3M
$28.2M
Q4 24
$-22.1M
$94.3M
Q3 24
$-9.2M
$72.9M
Q2 24
$7.4M
$50.8M
Gross Margin
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
HOV
HOV
Q1 26
3.6%
Q4 25
-10.1%
-0.5%
Q3 25
-4.9%
3.0%
Q2 25
-2.2%
3.9%
Q1 25
-0.3%
5.9%
Q4 24
-6.4%
12.0%
Q3 24
-2.7%
13.5%
Q2 24
2.0%
9.8%
Net Margin
CLOV
CLOV
HOV
HOV
Q1 26
3.6%
Q4 25
-10.1%
-0.1%
Q3 25
-4.9%
2.1%
Q2 25
-2.2%
2.9%
Q1 25
-0.3%
4.2%
Q4 24
-6.6%
9.6%
Q3 24
-2.8%
10.1%
Q2 24
2.1%
7.2%
EPS (diluted)
CLOV
CLOV
HOV
HOV
Q1 26
$0.05
Q4 25
$-0.57
Q3 25
$1.99
Q2 25
$2.43
Q1 25
$3.58
Q4 24
$12.47
Q3 24
$9.75
Q2 24
$6.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
HOV
HOV
Cash + ST InvestmentsLiquidity on hand
$177.6M
Total DebtLower is stronger
$900.7M
Stockholders' EquityBook value
$339.4M
$830.9M
Total Assets
$697.7M
$2.6B
Debt / EquityLower = less leverage
1.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
HOV
HOV
Q1 26
$177.6M
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Total Debt
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
$900.7M
Q3 25
$861.9M
Q2 25
$864.3M
Q1 25
$893.7M
Q4 24
$896.2M
Q3 24
$898.7M
Q2 24
$933.0M
Stockholders' Equity
CLOV
CLOV
HOV
HOV
Q1 26
$339.4M
Q4 25
$308.7M
$830.9M
Q3 25
$340.9M
$835.4M
Q2 25
$344.2M
$820.4M
Q1 25
$336.1M
$811.4M
Q4 24
$341.1M
$800.3M
Q3 24
$342.2M
$703.4M
Q2 24
$324.9M
$647.0M
Total Assets
CLOV
CLOV
HOV
HOV
Q1 26
$697.7M
Q4 25
$541.0M
$2.6B
Q3 25
$559.7M
$2.6B
Q2 25
$575.0M
$2.6B
Q1 25
$583.7M
$2.5B
Q4 24
$580.7M
$2.6B
Q3 24
$653.0M
$2.5B
Q2 24
$674.2M
$2.3B
Debt / Equity
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
1.08×
Q3 25
1.03×
Q2 25
1.05×
Q1 25
1.10×
Q4 24
1.12×
Q3 24
1.28×
Q2 24
1.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
HOV
HOV
Operating Cash FlowLast quarter
$169.1M
Free Cash FlowOCF − Capex
$164.0M
FCF MarginFCF / Revenue
20.0%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$166.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
$-66.9M
$169.1M
Q3 25
$12.1M
$52.8M
Q2 25
$5.4M
$22.3M
Q1 25
$-16.3M
$-55.9M
Q4 24
$34.8M
$115.8M
Q3 24
$50.0M
$-92.3M
Q2 24
$44.8M
$89.1M
Free Cash Flow
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
$-69.0M
$164.0M
Q3 25
$11.4M
$45.8M
Q2 25
$4.8M
$16.0M
Q1 25
$-16.5M
$-59.6M
Q4 24
$33.3M
$111.4M
Q3 24
$49.6M
$-95.8M
Q2 24
$44.4M
$84.7M
FCF Margin
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
-14.1%
20.0%
Q3 25
2.3%
5.7%
Q2 25
1.0%
2.3%
Q1 25
-3.6%
-8.8%
Q4 24
9.9%
11.4%
Q3 24
15.0%
-13.3%
Q2 24
12.5%
12.0%
Capex Intensity
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
0.4%
0.6%
Q3 25
0.1%
0.9%
Q2 25
0.1%
0.9%
Q1 25
0.0%
0.5%
Q4 24
0.5%
0.5%
Q3 24
0.1%
0.5%
Q2 24
0.1%
0.6%
Cash Conversion
CLOV
CLOV
HOV
HOV
Q1 26
Q4 25
Q3 25
3.18×
Q2 25
1.13×
Q1 25
-1.98×
Q4 24
1.23×
Q3 24
-1.27×
Q2 24
6.04×
1.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

HOV
HOV

Home Building$789.8M97%
Financial Services$28.1M3%
Management Fees$7.1M1%

Related Comparisons